|
Designated Public Office Holders who participated in the communication:
|
Samir Khan,
Associate Executive Director
Office of Pharmaceutical Management Strategies,
Health Canada (HC)
|
| |
List of Details
|
Subject matter
|
Detail
|
|
Health,
International Development,
Research and Development
|
Regulations, policies and programs related to the review and reimbursement processes of Health Canada, Canada’s Drug Agency and the pan-Canadian Pharmaceutical Alliance.
|
|
| |
|
Responsible Officer who filed this communication report:
|
Gaby Bourbara
|
| |
|
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
|
| |
